Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial.

[1]  Jacques P. Brown,et al.  Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .

[2]  J. Rodés,et al.  Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. , 1997, Gastroenterology.

[3]  Kenneth K Wang,et al.  Esophagitis associated with the use of alendronate. , 1996, The New England journal of medicine.

[4]  J Dequeker,et al.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.

[5]  E. Dickson,et al.  Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference? , 1995, Hepatology.

[6]  E. Dickson,et al.  Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. , 1994, Gastroenterology.

[7]  K. Lindor.  Management of Osteopenia of Liver Disease with Special Emphasis on Primary Biliary Cirrhosis , 1993, Seminars in liver disease.

[8]  T. Steiniche,et al.  Changes in bone histomorphometry after long‐term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  E. Silberstein,et al.  Cyclic oral phosphate and etidronate increase femoral and lumbar bone mineral density and reduce lumbar spine fracture rate over three years. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  J. Rodés,et al.  Sodium fluoride prevents bone loss in primary biliary cirrhosis. , 1992, Journal of hepatology.

[11]  E. Dickson,et al.  Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis , 1991, Hepatology.

[12]  S. Giannini,et al.  Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. , 1991, Journal of hepatology.

[13]  W. Mysiw,et al.  Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. , 1990, The New England journal of medicine.

[14]  H. Genant,et al.  Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. , 1990, The New England journal of medicine.

[15]  C. Record,et al.  A pilot, double‐blind, controlled 1‐year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss , 1989, Hepatology.

[16]  P. Grambsch,et al.  Prognosis in primary biliary cirrhosis: Model for decision making , 1989, Hepatology.

[17]  M. Bassendine,et al.  Metabolic bone disease in primary biliary cirrhosis at presentation. , 1988, Gastroenterology.

[18]  J. Compston.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. , 1986, Gut.

[19]  K. Mann,et al.  Bone loss and reduced osteoblast function in primary biliary cirrhosis. , 1985, Annals of internal medicine.

[20]  J. Compston,et al.  Osteoporosis in chronic cholestatic liver disease. , 1985, The Quarterly journal of medicine.

[21]  M. Kaplan,et al.  Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. , 1982, Gastroenterology.

[22]  R. Recker,et al.  Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. , 1982, Gastroenterology.

[23]  I. Rosenberg,et al.  Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D. , 1980, Gastroenterology.

[24]  J. Hay,et al.  Bone disease in cholestatic liver disease. , 1995, Gastroenterology.

[25]  E. Dickson,et al.  Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. , 1994, The American journal of gastroenterology.

[26]  R. Bergström,et al.  Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. , 1990, Annals of internal medicine.

[27]  M. Losowsky,et al.  Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease. , 1982, The Quarterly journal of medicine.